Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-649-3
CAS number: 33704-61-9
- Acute oral toxicity: LD50 is 2685 mg/kg bw (female) (method similar to OECD TG 401)- Acute inhalation toxicity: LD50 is 17400 mg/m3 (route-to-route extrapolation from acute oral toxicity study)- Acute dermal toxicity: LD50 is 2685 mg/kg bw (route-to-route extrapolation from acute oral toxicity study)
Acute oral toxicity
In an acute oral toxicity study (OECD TG 401), four groups of ten rats (five males and five females) were administered the test substance (test article 85-206-02) at dose levels of 2000, 3200, 4000 and 5000 mg/kg bw. The rats showed decreased activity, diarrhea, salivation, lacrimation, ptosis, poor grooming, piloerection, decreased or increased muscle tone, abnormal stance, abnormal gait, dyspnea, tremors, convulsions, wet pelage (ventral surface), red discoloration, writhing and prostration. 1 of 10 rats died at 2000 mg/kg, 5 of 10 died at 3200 mg/kg, 9 of 10 died at 4000 mg/kg and 10 of 10 died at 5000 mg/kg. Necropsy of the animals dying on the study revealed hemorrhagic lungs, discolored and fluid-filled intestines, distended stomachs and multiple lesions in the stomachs. The acute oral LD50 for the test substance in male and female rats was determined to be 2901 mg/kg bw with 95% CI of 2325 - 3619 mg/kg bw. The calculated LD50 for males was 3380 mg/kg bw (95% CI: 2907 - 3930 mg/kg bw). The calculated oral LD50 for females was 2685 mg/kg bw (95% CI: 2043 - 3529 mg/kg bw).
Acute dermal toxicity
With respect to the acute toxicity via the dermal route, the study is scientifically unjustified because the acute oral toxicity is above 2000 mg/kg bw. Based on the toxicokinetic data the dermal availability is not expected to exceed the oral availability. Therefore, the LD50 via the dermal route can be estimated to be similar to the oral LD50, because 50% absorption is assumed via both routes, resulting in an LD50 of 2685 mg/kg bw.
Acute inhalation toxicity
An acute inhalation toxicity study is not needed for substances with high viscosity (the substance has a viscosity of 31.7 mP.s) and acute oral and dermal toxicity values are available. For inhalation, an LD50 of 2900 mg/kg bw can be roughly converted into 174000 mg/per person by multiplying it with a person’s weight: (60 kg 2900 x 60=174000). An inhalation volume for one person during 4 h (standard exposure time in the OECD TG for acute inhalation is 5m3 (assuming 10m3/8h for workers). This means that an LC50 concentration in 1 m3 and 4 hours exposure is 34800 mg/m3 (174000mg/5m3). Taking into account that during that the absorption during the inhalation route is twice the oral route the LC50 and therefore the LC50 for inhalation could be 17400 mg/m3. The maximum saturates vapour pressure for Cashmeran is 84.7 mg/m3 (1 Pa (Vap Pr. Cashmeran) x 206 (MW) / 8.3 (R, gas constant) x 293 (°K)). This means that Cashmeran cannot reach a concentration higher than 84.7 mg/m3. Therefore, an LC50 for inhalation cannot be reached and no classification and labelling is needed for the acute inhalation route.
According to the criteria outlined in EU CLP (EC no 1272/2008 and its amendments), the substance does not have to be classified as acute toxic by the oral, dermal and inhalation route.
The substance has an LD50 of 2685 mg/kg bw (between 2000-5000 mg/kg bw) and therefore it needs to have hazard phrase H303: May be harmful if swallowed under GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again